Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Sleep Initiation and Maintenance Disorders 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
zopiclone × Clear all
NCT06219902 2024-05-08

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Bayer

Phase 1 Completed
64 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02807922 2021-07-16

Pharmacological Treatment of Insomnia in Palliative Care

St. Olavs Hospital

Phase 4 Completed
43 enrolled

Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡